跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 95,355 条关于
“anti-PD-L1 therapy”
全部
95,355
临床试验
65,447
药物
8,042
机构
197
资讯
21,669
去年
Glenmark Initiates Global Phase 3 Trial for Subcutaneous PD-L1 Inhibitor Envafolimab in Stage III Lung Cancer
2个月前
Phase 1b Trial Shows Short-Lived Anti-PD-L1 Antibody IBC-Ab002 Is Well Tolerated in Early Alzheimer's Disease
去年
Baseline Steroid Use Significantly Reduces Immune Checkpoint Inhibitor Effectiveness in NSCLC Patients
9年前
FDA Approves Bavencio: Merck KGaA and Pfizer's Breakthrough Immunotherapy for Rare Skin Cancer
去年
First Patient Dosed in Peluntamig Combination Therapy Trial for Small Cell Lung Cancer
去年
NSCLC Treatment Landscape: Biomarker Testing, Evolving Guidelines, and ADC Developments
去年
Cell and Gene Therapies Show Promise in Lung Cancer Treatment
去年
Atezolizumab Shows Promise Following Chemoradiotherapy in Advanced Esophageal Cancer
去年
FDA Grants Fast Track Designation to Phanes Therapeutics' PT217 for Neuroendocrine Prostate Cancer
去年
Gilead Withdraws Sacituzumab Govitecan's Bladder Cancer Approval After TROPiCS-04 Failure
第 1 页,共 2167 页
上一页
下一页